
Mefi Act P 500mg/325mg Tablet
Marketer
Burgeon Health Series Private Limited
Salt Composition
Mefenamic Acid (500mg) + Paracetamol (325mg)
Overview Mefi Act P 500mg/325mg Tablet
Combiflam P 500mg/325mg tablets contain a dual-action formulation for fever reduction. This medication effectively manages mild to moderate pain stemming from headaches, muscle aches, or dental pain. Always ingest Combiflam P with food to minimize stomach upset. Dosage is determined by your physician based on your condition and response to treatment. Strictly adhere to your doctor's prescribed dosage and duration. Common side effects may include nausea, vomiting, diarrhea, dyspepsia, anorexia, and pyrosis. Report any persistent or worsening side effects to your doctor, who can advise on mitigating strategies. Prior to commencing treatment, inform your doctor of any pre-existing conditions such as peptic ulcers, hypertension, or cardiac, renal, or hepatic impairment. Complete disclosure of all other medications you are currently using is crucial due to potential interactions.
Uses of Mefi Act P 500mg/325mg Tablet
Alleviating pain and reducing fever.
Major Benefits of Mefi Act P 500mg/325mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mefi Act P 500mg/325mg tablets should be taken with a meal.
Common Side effects of Mefi Act P 500mg/325mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Indigestion
- Loss of appetite
- Heartburn
How to use Mefi Act P 500mg/325mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the 500mg/325mg Mefi Act P Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
How Mefi Act P 500mg/325mg Tablet works:
Each Mefi Act P 500mg/325mg tablet unites mefenamic acid and paracetamol, effectively reducing fever, pain, and inflammation by inhibiting the production of specific inflammatory mediators.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Mefi Act 500mg/325mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Mefi Act P 500mg/325mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Seek medical advice before use.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Mefi Act P 500mg/325mg tablets are compatible. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Taking a Mefi Act P 500mg/325mg Tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should exercise caution when taking Mefi Act P 500mg/325mg tablets, as dosage modification may be necessary. Individuals with severe kidney disease should avoid this medication; a physician's consultation is recommended.
LiverCAUTION
Patients with liver impairment should use the 500mg/325mg Mefi Act P tablet cautiously, potentially requiring dosage modification. A physician's consultation is advised. This medication is contraindicated for individuals with severe or active liver disease.
What if you forget to take Mefi Act P 500mg/325mg Tablet :
Should you forget to take a Mefi Act P 500mg/325mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Mefi Act P 500mg/325mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
